Publications

by | May 31, 2015 | Uncategorized

General Data Protection Regulation – how to reconcile ethical and business concerns?

An event organised by the CEPS on 13 May 2015 provided an update of the status quo of the General Data Protection Regulation (GDPR) and presented issues under discussion during the Trilogue negotiations. Although the principal focus lay on stimulating dialogue between regulators and SMEs/start-ups, the debate also touched upon some health-related issues such as the development of eHealth as part of the Digital Single Market, and it brought up ethical questions related to the potential uses and misuses of data in an increasingly digitally-driven world.

The first panel reflected on the perspectives of entrepreneurs and the different challenges SMEs and start-ups are facing concerning data management and compliance, while trying to offer increasingly personalised services. In particular, the discussants representing the IT sector emphasised the importance of the need for legal clarity over the extent of explicit consent, and proposed to initiate a more nuanced discussion regarding the digital advertising industry. The latter comprised many different companies including providers of innovative data analytics services, as opposed to others, which engaged in aggressive profiling and tracking. Providers of cloud services could also guarantee high levels of security. Unsurprisingly, industry representatives argued in favour of establishing self- and co-regulation mechanisms.

But is this appropriate for health? The new challenges created by ICT regarding privacy, data ownership and trust are particularly sensitive in health. According to Raphael Van Assche, managing consultant at Tunstall Healthcare, trust and confidence should be part of the new Regulation in order to ensure better perspectives for business development in the EU. His company relies on patient data to provide better tailored and adapted (e-) healthcare services for older people and vulnerable groups. He also spoke in favour of greater harmonisation of rules at EU level, which would boost the European eHealth sector.

Michal Boni MEP (EPP, Poland) supported this argument by stating that trust and confidence are critical to ensure users’ fundamental rights while unleashing Europe’s innovation potential. He felt that the GDPR should strike the right balance between business interests and user protection but that it should also be easily implementable by SMEs. The 16 initiatives contained in the Digital Single Market Strategy would also be important for the Trialogue negotiations, which should be completed under the Luxembourgish Presidency by the end of the year. He also made a link with the new Medical Devices Regulation.

Overall, the debate brought to the fore the increasingly important question of defining the place of human decisions in technological processes and vis-a-vis data processing and portability. Participants agreed that technological standards based on security by-design and privacy by-default should be privileged, but they also needed to be more clearly defined. Clear liability rules are important, but a distinction should be made between different uses of data to ensure the further development of the digital economy; this was said to be especially important given that regulation trails behind technological progress.

From EPHA’s perspective, the question of what type of data protection and consent rules should apply in the healthcare sector is indeed dependent on the purpose of the data collection activity / service and the extent of personal data individuals are asked to provide. As members of the European Data in Health Research Alliance, EPHA calls for protecting health research from the detrimental consequences of amendments proposed by the European Parliament related to the obligation to provide specific consent for future uses of patient data.

At the same time, business interests should not reign over health interests. While it is true that notions of privacy are changing, this does not mean that people understand the implications of sharing data online. At the individual and consumer level, there are also growing concerns over having to accept complicated, often illegible and potentially misleading data protection protocols for accessing online services – including mHealth apps and eHealth services – and these should be taken very seriously. In addition to providing the required patient- or condition-specific information there is no real need for having to agree to share also location data, contacts, and other personal information (unless this is in line with the intended uses of a specific eHealth service, for example) for profiling and marketing purposes. This is a complex industry in which many SMEs create tailored health solutions, but it must never be allowed to stretch rules and regulations for profit-making purposes.

In order to find sustainable solutions, as advocated by Laure Wagener, Permanent Representation of Luxembourg, it is crucial to involve civil society stakeholders including health actors (professionals, patients and representatives of vulnerable groups) to ensure that a good balance can be struck.

—-
Related articles:
-[->5211]
-[->5438]
-[->4562]
-[->3797]

Get the EPHA Newsletter

The best of our activities, right in your inbox!